Skip to main content

Verastem, Inc 8-K, filed Nov 5, 2026

Verastem, Inc. (VSTM)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Verastem, Inc filed this 8-K on November 5, 2026.

Verastem reported $24.0M net product revenue and $422.8M pro forma cash, expecting cash runway into 1H 2028. RAMP 301 topline data are expected in mid-2027, while three Phase 3 trials are planned. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits